• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SUTURE UNKNOWN; SUTURE, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SUTURE UNKNOWN; SUTURE, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Urinary Tract Infection (2120)
Event Date 11/25/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that any of the ethicon products involved caused and/or contributed to the post-operative complications described in the article? which specific ethicon products have been used during the procedures (product code, lot number)? does the surgeon believe there was any deficiency with any of the ethicon products used in this procedure? if so, please provide details.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Patient demographics? this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.H6 component code: g07002 ¿ device not returned.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: chinese journal of practical gynecology and obstetrics, february 2022, vol.38, no.2; https://doi.Org/10.19538/j.Fk2022020117.
 
Event Description
Title: application of modified laparoscopic radical trachelectomy in cervical cancer for fertility preservation this study aims to evaluate the safety and feasibility of modified laparoscopic radical trachelectomy to preserve fertility in early-stage cervical cancer.From june 2017 to october 2020, 25 patients with early cervical cancer who received laparoscopic radical trachelectomy + pelvic lymphadenectomy were included in the study.13 patients (mean age 31.8 ± 4.84 years) received traditional laparoscopic surgery and 12 patients (mean age 29.2 ± 3.94 years) received modified laparoscopic surgery.All patients underwent pelvic lymphadenectomy at the beginning of surgery.In the modified laparoscope group, before preparing the vagina for transection, the vaginal wall was sutured with a 2-0 suture (johnson & johnson) purse-string 2 cm below the cervix to avoid tumor exposure.The cervix was cut 5 mm below the uterine canyon, the vagina was cut below the vaginal purse-string suture, and the resected cervix and parametrium were sent for frozen pathological examination, and if the tumor was < 5 mm from the resection margin, the uterus was abandoned, and if the tumor was = 5 mm from the resection margin, the residual cervix was sutured to the vagina for reconstruction.In the traditional laparoscopic group, except a uterine elevator was used and purse-string suture was not performed before vaginal incision.Reported complications included fever (n=4) and urinary tract infection (n=1).In conclusion, the application of modified laparoscopic radical trachelectomy in early-stage cervical cancer is safe and feasible, and whether it can further improve the tumor outcome and pregnancy rate needs to be further confirmed by large randomized controlled trials.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUTURE UNKNOWN
Type of Device
SUTURE, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key18526936
MDR Text Key333043462
Report Number2210968-2024-00474
Device Sequence Number1
Product Code GAK
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/08/2024
Initial Date FDA Received01/17/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-